share_log

PetMed Express Analyst Ratings

PetMed Express Analyst Ratings

PetMed 快报分析师评级
Benzinga ·  2023/10/19 07:39
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/19/2023 -1.57% Morgan Stanley $17 → $10 Maintains Underweight
07/27/2023 67.32% Morgan Stanley $17 → $17 Reiterates Underweight → Underweight
05/25/2023 96.85% Lake Street → $20 Initiates Coverage On → Buy
03/23/2023 67.32% Morgan Stanley $18 → $17 Maintains Underweight
11/08/2022 77.17% Morgan Stanley $19 → $18 Maintains Underweight
07/26/2022 87.01% Morgan Stanley $20 → $19 Maintains Underweight
05/10/2022 96.85% Morgan Stanley $21 → $20 Maintains Underweight
01/25/2022 106.69% Morgan Stanley $25 → $21 Maintains Underweight
01/20/2022 214.96% Sidoti & Co. → $32 Upgrades Neutral → Buy
11/18/2021 146.06% Morgan Stanley → $25 Initiates Coverage On → Underweight
10/01/2021 175.59% Jefferies → $28 Initiates Coverage On → Hold
06/03/2021 283.86% Sidoti & Co. → $39 Downgrades Buy → Neutral
03/05/2021 Sidoti & Co. Upgrades Neutral → Buy
08/19/2020 303.54% Sidoti & Co. $37 → $41 Upgrades Neutral → Buy
02/24/2020 Sidoti & Co. Downgrades Buy → Neutral
10/17/2019 96.85% Craig-Hallum $15 → $20 Maintains Hold
08/16/2019 Craig-Hallum Downgrades Buy → Hold
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
2023 年 10 月 19 日 -1.57% 摩根士丹利 17 美元 → 10 美元 维持 体重不足
07/27/2023 67.32% 摩根士丹利 17 美元 → 17 美元 重申 体重过轻 → 体重不足
05/25/2023 96.85% 湖街 → 20 美元 启动覆盖范围开启 → 购买
03/23/2023 67.32% 摩根士丹利 18 美元 → 17 美元 维持 体重不足
2022 年 8 月 11 日 77.17% 摩根士丹利 19 美元 → 18 美元 维持 体重不足
07/26/2022 87.01% 摩根士丹利 20 美元 → 19 美元 维持 体重不足
05/10/2022 96.85% 摩根士丹利 21 美元 → 20 美元 维持 体重不足
01/25/2022 106.69% 摩根士丹利 25 美元 → 21 美元 维持 体重不足
01/20/2022 214.96% Sidoti & Co. → 32 美元 升级 中性 → 买入
11/18/2021 146.06% 摩根士丹利 → 25 美元 启动覆盖范围开启 → 体重不足
10/01/2021 175.59% 杰富瑞集团 → 28 美元 启动覆盖范围开启 → 按住
06/03/2021 283.86% Sidoti & Co. → 39 美元 降级 买入 → 中性
03/05/2021 Sidoti & Co. 升级 中性 → 买入
2020 年 8 月 19 日 303.54% Sidoti & Co. 37 美元 → 41 美元 升级 中性 → 买入
2020 年 2 月 24 日 Sidoti & Co. 降级 买入 → 中性
10/17/2019 96.85% Craig-Hallum 15 美元 → 20 美元 维持 按住
2019 年 8 月 16 日 Craig-Hallum 降级 买入 → 持有

What is the target price for PetMed Express (PETS)?

PetMed Express (PETS) 的目标价格是多少?

The latest price target for PetMed Express (NASDAQ: PETS) was reported by Morgan Stanley on October 19, 2023. The analyst firm set a price target for $10.00 expecting PETS to fall to within 12 months (a possible -1.57% downside). 5 analyst firms have reported ratings in the last year.

摩根士丹利于2023年10月19日公布了PetMed Express(纳斯达克股票代码:PETS)的最新目标股价。该分析公司将目标股价设定为10.00美元,预计PETS将在12个月内跌至-1.57%(下跌幅度可能为-1.57%)。去年有5家分析公司公布了评级。

What is the most recent analyst rating for PetMed Express (PETS)?

分析师对PetMed Express(PETS)的最新评级是多少?

The latest analyst rating for PetMed Express (NASDAQ: PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.

摩根士丹利提供了PetMed Express(纳斯达克股票代码:PETS)的最新分析师评级,PetMed Express维持其减持评级。

When is the next analyst rating going to be posted or updated for PetMed Express (PETS)?

PetMed Express(PETS)的下一个分析师评级何时公布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on October 19, 2023 so you should expect the next rating to be made available sometime around October 19, 2024.

分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与PetMed Express的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月进行一次评级,因此每家公司每年应获得4个评级。PetMed Express的最后一次评级是在2023年10月19日提交的,因此您应该预计下一个评级将在2024年10月19日左右公布。

Is the Analyst Rating PetMed Express (PETS) correct?

分析师对 PetMed Express (PETS) 的评级正确吗?

While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $17.00 to $10.00. The current price PetMed Express (PETS) is trading at is $10.16, which is out of the analyst's predicted range.

尽管评级是主观的,并将发生变化,但最新的PetMed Express(PETS)评级维持不变,目标股价为17.00美元至10.00美元。PetMed Express(PETS)目前的交易价格为10.16美元,超出了分析师的预测区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发